ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "COVID-19"

  • Abstract Number: 0430 • ACR Convergence 2020

    Outcomes of Coronavirus Disease 2019 Infection Among Patients Living with Rheumatic Diseases: A Matched Cohort Study from a US Multi-Center Research Network

    Kristin D'Silva1, April Jorge1, Na Lu2, Yuqing Zhang3, Zachary Wallace4 and Hyon Choi5, 1Massachusetts General Hospital, Boston, MA, 2Arthritis Research Canada, Vancouver, BC, Canada, 3Massachusetts General Hospital, Quincy, MA, 4Massachusetts General Hospital, Newton, MA, 5Massachusetts General Hospital, Department of Medicine, Division of Rheumatology, Lexington, MA

    Background/Purpose: Whether patients living with systemic autoimmune rheumatic diseases (SARDs) suffer from more severe complications of Coronavirus Disease 2019 (COVID-19) infection remains unknown.Methods: We conducted…
  • Abstract Number: 0587 • ACR Convergence 2020

    Barriers to Rheumatologic Care and Antimalarial Refills Among a Cohort of Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic

    Alfredo Aguirre1, Laura Trupin1, Sarah Patterson2, Kimberly DeQuattro2, Patricia Katz3, Cristina Lanata2, Stephanie Rush1, Lindsey Criswell4, Maria Dall'Era5 and Jinoos Yazdany1, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3University of California, San Francisco, Novato, CA, 4Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, University of California San Francisco, San Francisco, CA, 5Division of Rheumatology, University of California, San Francisco, CA

    Background/Purpose: The pandemic of coronavirus disease 19 (COVID-19) has led to widespread disruptions across the spectrum of healthcare. We sought to investigate barriers to medical…
  • Abstract Number: 0636 • ACR Convergence 2020

    Rheumatology Patient Experience and Trends During the SARS-COV-2 Pandemic

    Cuoghi Edens1, Kichul Ko1 and Kimberly Trotter1, 1University of Chicago, Chicago, IL

    Background/Purpose: Rheumatic disease patients are counseled on the immunosuppressive aspect of their rheumatic disease treatment and their increased risk of infection.  Little is known about…
  • Abstract Number: 1275 • ACR Convergence 2020

    Unexpected Changes in Physical and Psychological Measures Among Georgia Lupus Patients During the Early Weeks of the COVID-19 Pandemic in the United States, March 30–April 21, 2020

    S. Sam Lim1, Kristina Theis2, Charmayne Dunlop-Thomas1, Gaobin Bao1, Charles Helmick2, Caroline Gordon3 and Cristina Drenkard4, 1Emory University, Atlanta, GA, 2Centers for Disease Control and Prevention, Atlanta, GA, 3University of Birmingham, Birmingham, England, United Kingdom, 4Division of Rheumatology, Department of Medicine, Emory School of Medicine, Atlanta, GA

    Background/Purpose: An infectious disease outbreak can lead to negative physical and psychological consequences in the general public, as shown by the early COVID-19 pandemic, through…
  • Abstract Number: 1627 • ACR Convergence 2020

    Phase I Trial of High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients with Mild COVID-19: A Study in the Effects of Shifting Public Opinion on Patient Enrollment

    Patrick Onkka1, Pankti Reid1, Iazsmin Bauer Ventura1, Brian Labadie2 and Reem Jan1, 1University of Chicago, Chicago, IL, 2University of Chicago, Chicago

    Background/Purpose: Coronavirus disease 2019 (COVID-19) was first recognized in December 2019 and quickly became a global pandemic within months. Amidst a myriad of uncertainties, early…
  • Abstract Number: 0014 • ACR Convergence 2020

    Does the Type of Rheumatic Disease or Biologic Treatment Increase the Risk of Developing Severe COVID-19?

    Fernando López-Gutierrez1, Antía García-Fernández1, Jesús Loarce-Martos1, Laura Calvo-Sanz1, Ivan Del Bosque-Granero2, Veronica Garcia2, Boris Blanco-Cáceres1, Cristina Pijoan-Moratalla1, Lourdes Villalobos-Sánchez3, Javier Bachiller-Corral1 and Mónica Vázquez1, 1Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, 2Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Madrid, Spain, 3Rheumatology, Hospital Universitario Ramón y Cajal, Madrid

    Background/Purpose: Patients with inflammatory rheumatic diseases (IRD) have an increased risk for infection related to immunosuppression secondary to their disease, treatment and comorbidities. Nonetheless recent…
  • Abstract Number: 0434 • ACR Convergence 2020

    Changes in Mental Health During the COVID-19 Pandemic Among Individuals with Rheumatic Disease

    Patricia Katz1, Sofia Pedro2, Kristin Wipfler3, Teresa Simon4, Yomei Shaw5, Adam Cornish6 and Kaleb Michaud7, 1University of California, San Francisco, Novato, CA, 2FORWARD-The National Data Bank for Rheumatic Diseases, Wichita, 3FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 4Bristol-Myers Squibb Company (at time of analysis), Princeton, NJ, 5Forward, The National Databank for Rheumatic Diseases, East Lansing, MI, 6FORWARD, 68134, NE, 7University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Symptoms of both depression and anxiety are often elevated among individuals with rheumatic conditions, and stress levels may play a role in each.  Depression,…
  • Abstract Number: 0592 • ACR Convergence 2020

    A Rheumatology-Driven Protocol and Treatment Algorithm of SARS-CoV-2 Cytokine Release Syndrome and Its Associated Outcomes

    Sandy Lee1, Neha Chiruvolu2, Muntarin Karim3, Patil Injean4, Loomee Doo5, Donna Jose6, Deepa Panikkath1, Micah Yu5, Anna Lafian5, Wendy De La Pena7, Albert Chow8, Karina Torralba9, Vaneet Sandhu10, Mehrnaz Hojjati5, Marven Cabling5 and Christina Downey1, 1Loma Linda University Medical Center, Redlands, CA, 2UC Riverside School of Medicine, Riverside, CA, 3Loma Linda University Health System, Loma Linda, CA, 4LOMA LINDA UNIVERSITY MEDICAL CENTER - RHEUMATOLOGY, Redlands, CA, 5Loma Linda University Medical Center, LOMA LINDA, CA, 6Loma Linda University Medical Center, Ontario, CA, 7PRCSG, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8Loma Linda University, San Bernardino, CA, 9Loma Linda University School of Medicine, Redlands, CA, 10Loma Linda University, Loma Linda, CA

    Background/Purpose: The newly identified SARS-CoV-2 has brought Cytokine Release Syndrome (CRS) to a level of prominence not often seen in adult medicine. Mortality rates of…
  • Abstract Number: 0638 • ACR Convergence 2020

    Serological Evidence of SARS-CoV-2 in Symptomatic Patients Under Biological Treatment in a Rheumatology Service

    Cristobal Pavez Perales1, Samuel Leal Rodriguez2, Marta De la Rubia Navarro1, Roxana Gonzalez Mazario1, Elena Grau Garcia3, Cristina Alcañiz Escandell3, Inmaculada Chalmeta Verdejo1, Jorge Juan Fragio Gil1, Luis Gonzalez Puig4, Jose Ivorra Cortes1, Isabel Martinez Cordellat1, Rosa Negueroles Albuixech1, Jose Eloy Oller Rodriguez1, Francisco Miguel Ortiz Sanjuan5, Elvira Vicens Bernabeu2 and Jose Andres Roman Ivorra1, 1Rheumatology Department. HUP La Fe, Valencia, Spain, 2Rheumatology Department, HUP La Fe, Valencia, Spain, 3Rheumatology Department. HUP La Fe, Valencia, Comunidad Valenciana, Spain, 4Rheumatology Department. HUP La Fe, Torrente ( Valencia), Spain, 5La Fe University Hospital, Valencia

    Background/Purpose: In mid-March 2020, state of alarm was declared in Spain due to the novel coronavirus disease 2019 (COVID-19) pandemic. Patients with rheumatic diseases (RD)…
  • Abstract Number: 1279 • ACR Convergence 2020

    Clinical Characteristics and Impact of the COVID-19 Pandemic in Systemic Lupus Erythematosus Patients in a Spanish Tertiary Hospital

    Andrea Briones-Figueroa1, María Jesús García-Villanueva2, África Andreu Suárez1, Marina Tortosa-Cabañas2, Ana Corral-Bote2, Sandra Garrote-Corral2, Javier Bachiller-Corral1 and Mónica Vázquez1, 1Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, 2Hospital Universitario Ramón y Cajal, Madrid, Spain

    Background/Purpose: Data about incidence, clinical characteristics and outcome of patients with Systemic Lupus Erythematosus (SLE) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease is…
  • Abstract Number: 1685 • ACR Convergence 2020

    Impact of the COVID-19 Pandemic Among Children with Rheumatic Diseases from Around the Globe

    Jonathan Hausmann1, Kevin Kennedy2, Salman Surangiwala3, Maggie Larche4, Karen Durrant5, Rashmi Sinha6 and Emily Sirotich4, 1Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, 2McMaster University, Hamilton, Canada, 3Queen’s School of Medicine, Kingston, Canada, 4McMaster University, Hamilton, ON, Canada, 5Autoinflammatory Alliance, San Francisco, CA, 6SJIA Foundation, Cincinnati

    Background/Purpose: Children with rheumatic diseases face unknown risks in the setting of the COVID-19 pandemic.  These children are often immunosuppressed due to their underlying disease…
  • Abstract Number: 0015 • ACR Convergence 2020

    COVID -19 Lung Inflammation – What Have We Learnt so Far ?

    Sriya Gokaraju1, Maria Darda2, Vinod Vijayaraghavan Nalini Warrier3, Irina Duta3, Fiona Hayes3, Yasser Ahmed4 and Gouri Koduri3, 1Southend University Hospital NHS Trust, Essex, United Kingdom, 2Southend University Hospital NHS Trust, Essex, United Kingdom, 3Southend University Hospital NHS Trust, Essex, United Kingdom, 4Southend University Hospital, Essex, United Kingdom

    Background/Purpose: The SARS CoV-2 pandemic has inspired new interest in understanding the fundamental pathology of pneumonia and Acute Respiratory Distress Syndrome (ARDS). SARS CoV-2 in…
  • Abstract Number: 0435 • ACR Convergence 2020

    Low Incidence of Coronavirus Disease 2019 (COVID-19) Infection in Patients on Biologic Infusion Therapies at a Community Rheumatology Practice

    Julie Keegan Strosser1, Ronald Yglesias2 and Norman Gaylis1, 1Arthritis & Rheumatic Disease Specialties, Aventura, FL, 2Arthritis & Rheumatic Disease Specialties, Hialeah, FL

    Background/Purpose: Following the first documented Florida case of COVID-19 on March 1, 2020, our community rheumatology practice continued to administer biologic infusion therapy with concern…
  • Abstract Number: 0595 • ACR Convergence 2020

    High Satisfaction with Tele-medicine in a New York City Clinic

    Tommy Chen1, Cathy Guo1, Wei Tang1, Leila Khalili1 and Anca Askanase2, 1Columbia University Medical Center, New York, NY, 2Columbia University College of Physicians & Surgeons, New York, NY

    Background/Purpose: The face of medicine is changing with the time. A twenty-first century technological revolution in medicine happened in March 2020 as the COVID-19 pandemic…
  • Abstract Number: 0639 • ACR Convergence 2020

    Immunological Abnormalities in a SARS-CoV-2-Cytokine Release Syndrome Rheumatology Cohort

    Patil Injean1, Sandy Lee1, Neha Chiruvolu2, Muntarin Karim3, Loomee Doo4, Deepa Ragesh Panikkath5, Donna Jose4, Micah Yu4, Anna Lafian4, Vaneet Sandhu6, Karina Torralba7, Christina Downey1, Marven Cabling8 and Mehrnaz Hojjati9, 1Loma Linda University Medical Center, Redlands, CA, 2UC Riverside School of Medicine, Riverside, CA, 3Loma Linda University Health System, Loma Linda, CA, 4Loma Linda University Medical Center, Loma Linda, CA, 5Loma Linda University Health, Department of Rheumatology, Loma Linda, CA, 6Loma Linda University, Loma Linda, CA, 7Loma Linda University School of Medicine, Redlands, CA, 8Loma Linda University Medical Center, Loma Linda, 9Loma Linda University, Loma Linda

    Background/Purpose: Cytokine release syndrome (CRS) is a condition characterized by a sepsis-like condition and laboratory abnormalities such as high ferritin, low ESR, and low fibrinogen…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology